GASTROESOPHAGEAL CANCER

This study compares two different stomach cancer surgeries to see which one causes fewer appetite problems after the operation. Researchers will track 20 patients with early-stage stomach cancer who receive either a partial or full stomach removal. The goal is to determine which …

This study is testing if a more aggressive approach can better control advanced stomach cancer that has spread a little. Patients receive a combination of immunotherapy and chemotherapy drugs. Then, some patients will also have surgery or other local treatments to remove tumors, …

This study is testing an experimental drug called zanidatamab for people with advanced cancers that have a specific genetic marker called HER2. The trial will enroll about 200 adults whose cancers have progressed after at least one prior treatment. Researchers want to see if the …

This study is testing a new combination of four drugs for people with advanced stomach or esophageal cancer that has a specific genetic feature called HER2. The goal is to see if adding the drug neratinib to standard chemotherapy and two other targeted drugs is safe and more effe…

This is an early-stage study testing a new oral drug called BG-68501 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see how the body processes the drug, both when given alone and when combined with…

This study is testing whether a remote support program can help people with stomach or esophageal cancer avoid malnutrition during treatment. Participants will use a phone app to track food and meet with a dietitian remotely, comparing this approach to usual care. The goal is to …

This study aims to collect blood and tissue samples from people with various cancers to help develop better blood tests. Researchers want to see if these tests can detect tiny amounts of leftover cancer cells after treatment, which might help predict if the cancer could return. P…